Literature DB >> 8520077

Estimating phenytoin concentrations by the Sheiner-Tozer method in adults with pronounced hypoalbuminemia.

W E Dager1, J F Inciardi, T L Howe.   

Abstract

OBJECTIVE: To assess the performance of the Sheiner-Tozer equation when used to evaluate total phenytoin concentrations in patients with pronounced hypoalbuminemia.
DESIGN: Patients with phenytoin concentrations drawn at least 5 days after initiation of therapy and with serum albumin concentrations of less than 25 g/L were identified during routine daily monitoring. Phenytoin samples were frozen at -30 degrees C, batched, and later thawed for total and free phenytoin assay. Separation of free phenytoin concentration was performed at 37 degrees C using a Centrifree micropartition filter.
SETTING: A 400-bed university teaching hospital. PATIENTS: Twenty-nine adults with hypoalbuminemia receiving phenytoin therapy. Patients receiving drugs known to displace phenytoin, or those with renal failure, abnormal liver enzymes, or increased bilirubin concentrations were excluded. MAIN OUTCOME MEASURE: Precision and bias of the normalized result using the Sheiner-Tozer equation were assessed with respect to observed phenytoin concentrations.
RESULTS: The Sheiner-Tozer equation underpredicts the measured free concentration by approximately 12.4%. The equation provides a small but statistically significant bias (-2.7 mg/L) and a root mean squared error significantly different from 0. For most of our patients these departures appear small enough to warrant an initial empiric appraisal of hypoalbuminemia using the Sheiner-Tozer method.
CONCLUSIONS: The Sheiner-Tozer equation can normalize total phenytoin concentrations reliably in patients with low albumin concentrations at our institution.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520077     DOI: 10.1177/106002809502907-802

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  8 in total

1.  Alaska.

Authors: 
Journal:  Mod Healthc (Short Term Care)       Date:  1975-12

2.  Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.

Authors:  Kim Vanstraelen; Joost Wauters; Ine Vercammen; Henriette de Loor; Johan Maertens; Katrien Lagrou; Pieter Annaert; Isabel Spriet
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

Review 3.  Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis.

Authors:  Anis Chaari; Alaa Sayed Mohamed; Karim Abdelhakim; Vipin Kauts; William Francis Casey
Journal:  Int J Clin Pharm       Date:  2017-08-05

4.  Effect of blood decrease on micafungin disposition in rats.

Authors:  Hiroki Konishi; Keizo Fukushima; Masatomo Sudo; Masaki Sumi; Tokuzo Minouchi; Ikumi Iga; Nobuhito Shibata; Akira Yamaji
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-02-25       Impact factor: 2.441

5.  Predictive Performance of the Winter-Tozer and Derivative Equations for Estimating Free Phenytoin Concentration.

Authors:  Wendy Cheng; Tony K L Kiang; Penny Bring; Mary H H Ensom
Journal:  Can J Hosp Pharm       Date:  2016-08-31

6.  Free phenytoin assessment in patients: measured versus calculated blood serum levels.

Authors:  Andrea Tobler; Raphael Hösli; Stefan Mühlebach; Andreas Huber
Journal:  Int J Clin Pharm       Date:  2016-01-08

7.  Positive Patient Postoperative Outcomes with Pharmacotherapy: A Narrative Review including Perioperative-Specialty Pharmacist Interviews.

Authors:  Richard H Parrish; Heather Monk Bodenstab; Dustin Carneal; Ryan M Cassity; William E Dager; Sara J Hyland; Jenna K Lovely; Alyssa Pollock; Tracy M Sparkes; Siu-Fun Wong
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964

8.  A Novel Correction Equation Avoids High-Magnitude Errors in Interpreting Therapeutic Drug Monitoring of Phenytoin Among Critically Ill Patients.

Authors:  Megan E Barra; Kristy M Phillips; David Y Chung; Eric S Rosenthal
Journal:  Ther Drug Monit       Date:  2020-08       Impact factor: 3.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.